News coverage about Core Laboratories (NYSE:CLB) has been trending somewhat positive this week, Accern Sentiment reports. Accern identifies positive and negative media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Core Laboratories earned a media sentiment score of 0.20 on Accern’s scale. Accern also gave press coverage about the oil and gas company an impact score of 45.5363224332413 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
A number of equities analysts recently commented on the company. Piper Jaffray Companies assumed coverage on Core Laboratories in a report on Tuesday, March 13th. They set a “neutral” rating and a $96.00 price target for the company. Zacks Investment Research upgraded Core Laboratories from a “hold” rating to a “buy” rating and set a $120.00 price target for the company in a report on Wednesday, April 4th. ValuEngine cut Core Laboratories from a “buy” rating to a “hold” rating in a report on Wednesday, June 6th. Finally, Citigroup raised their price objective on shares of Core Laboratories from $117.00 to $123.00 and gave the stock a “neutral” rating in a research report on Monday, April 30th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and four have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $115.63.
Core Laboratories opened at $125.27 on Wednesday, according to Marketbeat.com. The company has a debt-to-equity ratio of 1.55, a current ratio of 2.11 and a quick ratio of 1.76. Core Laboratories has a 1-year low of $86.55 and a 1-year high of $130.34. The company has a market capitalization of $5.53 billion, a PE ratio of 62.64 and a beta of 1.40.
Core Laboratories (NYSE:CLB) last released its quarterly earnings results on Wednesday, April 25th. The oil and gas company reported $0.57 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.57. Core Laboratories had a net margin of 13.24% and a return on equity of 62.69%. The company had revenue of $170.00 million during the quarter, compared to the consensus estimate of $171.03 million. During the same period in the previous year, the business earned $0.42 earnings per share. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. sell-side analysts anticipate that Core Laboratories will post 2.71 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, May 22nd. Stockholders of record on Friday, April 27th were given a $0.55 dividend. The ex-dividend date was Thursday, April 26th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 1.76%. Core Laboratories’s payout ratio is 110.00%.
About Core Laboratories
Core Laboratories N.V. provides reservoir description, and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs.
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.